CN Patent

CN106580960A — 一种维格列汀和盐酸二甲双胍复方制剂的制备方法

Assigned to Nanjing Yoko Biological Pharmaceutical Group Co Ltd · Expires 2017-04-26 · 9y expired

What this patent protects

本发明公开了一种维格列汀和盐酸二甲双胍复方制剂的制备方法，通过将盐酸二甲双胍、粘合剂和维格列汀过筛混合，干法制粒，加入润滑剂总混，取样检测和压片等工序。该工艺制得的片剂解决了维格列汀的含量均匀度，同时改善了片剂的可压性及流动性，脆碎度和硬度符合药典质量标准，稳定性较好，操作简单，生产成本低，可以实现工业化。

USPTO Abstract

本发明公开了一种维格列汀和盐酸二甲双胍复方制剂的制备方法，通过将盐酸二甲双胍、粘合剂和维格列汀过筛混合，干法制粒，加入润滑剂总混，取样检测和压片等工序。该工艺制得的片剂解决了维格列汀的含量均匀度，同时改善了片剂的可压性及流动性，脆碎度和硬度符合药典质量标准，稳定性较好，操作简单，生产成本低，可以实现工业化。

Drugs covered by this patent

Patent Metadata

Patent number
CN106580960A
Jurisdiction
CN
Classification
—
Expires
2017-04-26
Drug substance claim
No
Drug product claim
No
Assignee
Nanjing Yoko Biological Pharmaceutical Group Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.